Hello World. We're excited to launch Dimension today! Dimension is a first-of-its-kind firm partnering with founders at the interface of technology & life sciences to transform the trajectory of life on earth. For a decade we've honed our investment instincts & philosophies at the cutting edge of life science & technology & have stitched together a new ilk of enterprise alongside many of the planet’s greatest scientists, technologists & founders At the frontiers of the recent-possible we saw the hidden in plain sight truth: it wasn’t a question of if or when the realms of technology & life sciences would collide. They already had. Today we're announcing Dimension 1; a $350M fund investing at the earliest stages - incubation through growth - of drug discovery platforms, machine learning, tools, services, instruments & software companies digitizing the world of life sciences The digitization of life sciences will transform the entire end-to-end journey of medicines: from the Eureka moment of biological discovery, to lab tools, instruments & software, to clinical development, to regulatory interface, & ultimately to manufacturing & commercialization. And tomorrow’s biotechs will no longer be formed by a team of two: a biologist & a chemist, but instead a team of three: a biologist, chemist, & computer scientist We founded Dimension to partner with the very best entrepreneurs working across this continuum while aspiring to become a beacon and lighthouse for the greater and emerging ecosystem If this speaks to you - and our conviction is that there are MANY of you ideating, experimenting, coding & building - please reach out. We want to be on that world changing journey with you! www.dimensioncap.com
About us
A first-of-its-kind fund partnering with founders at the interface of technology and life sciences to transform the trajectory of life on earth
- Website
-
https://www.dimensioncap.com/
External link for Dimension
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 2-10 employees
- Headquarters
- New York, New York
- Type
- Partnership
Locations
-
Primary
New York, New York 10013, US
-
San Francisco, CA 94104, US
Employees at Dimension
Updates
-
Today we’re 🚀 launching 🚀 Dimension cofounded Achira with the mission to build atomistic foundation simulation models to power the future of drug discovery. Thrilled to have partnered with amazing co-founders John Chodera and Theofanis Karaletsos and excited to have NVIDIA, Amplify Partners and Compound build alongside us 💪 Check out more at achira.ai and thank you Andrew Dunn for the coverage! https://lnkd.in/euJqdXQf
-
Will there be a singular "DeepSeek moment" for the burgeoning intersection of ML + Biology? DeepSeek's launch re-rated the value of GPU stashes, costing Nvidia over $500B in equity market cap in a single session. So, how is biology different? Will an open-source screaming meteor shatter the field's firmament and force us all to question our priors? Read more from Dimension Research Simon Barnett 👨🔬 💻 🔬 https://lnkd.in/eRQhXmjP
DeepSeek Shocked Silicon Valley, but It’s Not Earth Shaking for Biotech - TimmermanReport.com
https://timmermanreport.com
-
Excited to announce the promotion of Simon Barnett to Partner and Head of Research. This goes hand-in-hand with Dimension II, $500M of fresh capital, for which Simon will continue to help lead, build and invest at the frontiers of technology and science. As we transition over to Dimension II, we plan to grow our efforts in building out world class tooling and research with the mission to find ground truth in everything that we do. Much more to come! 🚀 🚀
-
-
🚨 Announcing our latest investment in Aspect Biosystems, leading their oversubscribed $115M financing 🚨 We're super excited to be partnering with Tamer Mohamed and the entire Aspect team as they lead the way in building a new class of regenerative medicines! Read more about our investment here by Nan Li https://lnkd.in/e62xUstK
Investing In Aspect Biosystems
dimensioncap.com
-
The Dimension team just attended NeurIPS. Below is our recap of key themes and advancements from the conference. Enjoy!
Last week, Reha Mathur, Bauer LeSavage, and I attended several ML + Biology workshops at NeurIPS 2024. We've compiled all of our notes below as a community resource. We hope you enjoy! https://lnkd.in/eCaKKiP6
NeurIPS 2024 Open Notes
research.dimensioncap.com
-
Thanks Brad Loncar for having Zavain Dar on BiotechTV. We're massive fans of yours! https://lnkd.in/g7sQ9Nvt
Dimension's Zavain Dar talks about raising a $500M second fund, and describes the firm's ethos of investing in companies that are highly focused in both life sciences and technology
biotechtv.com
-
Thanks for the fun chat Allison and for your awesome coverage of the space! Off to do our EOY expense reports 😜
What happens when two computer scientists and a former stem cell researcher become friends while working their way up the venture capital corporate ladder and decide to start their own firm? Well, in Dimension’s case, they end up investing in some buzzy AI startups, counseling pharmaceutical companies, ribbing one another about expense reports, and — as of Monday — are able to raise $500 million for their second fund. Read more on Dimension and its investments in life sciences software tools to therapeutics companies, manufacturing firms, and more at STAT. #biotech #techbio #venturecapital #VC #AI #machinelearning #fundraising #founder #founderstories #investing #healthcare #lifesciences
Young biotech venture firm raises $500 million for its second fund
https://www.statnews.com
-
Fun conversation as always Kyle. Thanks for the kind words! 🚀
Dimension quickly secured $500 million for its sophomore life sciences fund, and it'll help build about 20 to 24 startups. The VC firm's trio of leaders — Nan Li, Zavain Dar and Adam Goulburn — have an "evergreen" whiteboard of entrepreneurs they want to work with. They partnered with the "vast majority" of the names on the "dream list" for their first fund and hope to do so again with this new batch of capital. “People are now paying more attention to techbio, or bio and machine learning, than they were two years ago,” Dar said in an interview with Endpoints News. “I think it’s still contrary to be investing in this way. The tension still is not where it should be.” #biotechvc #biotechinvesting #lifesciencesvc #dimension #biotechstartups #vcfund #techbio
Dimension nabs $500M second fund for 'still contrary' intersection of bio and machine learning
endpts.com